Trial intelligence / Profile preview

FlutiForm vs Seretide in paediatric asthma

2006-005928-16Phase 3Completed

Sponsor
Mundipharma Research
Start
Jan 2007
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of fluticasone propionate + formoterol in asthma (2 arms), sponsored by Mundipharma Research. Primary endpoint: Forced Expiratory Volume in 1 second (FEV1). Started Jan 2007; status: completed.

02

Drugs

fluticasone propionate + formoterol
03

Conditions

asthma

Beyond the preview

Go deeper on 2006-005928-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005928-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call